Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1990 Feb;136(2):467–477.

Inflammatory exudates in skin windows induced by 1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine.

D M Humphrey 1
PMCID: PMC1877408  PMID: 2407127

Abstract

Previously identified as a platelet-activating factor, 1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine recently has been described as an inflammatory mediator with vasoactive and leukotactic properties. Histologic studies suggested that the local microvascular effects of this potent acetylated alkyl phosphoglyceride were limited in extent. Also, cytologic characterization of exudates was incomplete in tissue sections. Therefore, skin window chambers were used as an alternate model in which to explore the ability of the active form of this lipid mediator to diffuse in tissue. In addition, skin windows provided a convenient means to characterize the leukocytic exudates. Based on measurements of agonist-induced plasma exudation, the effect of 1-0-hexadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine appeared to be limited to the superficial microvasculature underlying the skin window surface. This interpretation was supported by a brief histologic study that revealed vascular labeling by colloidal carbon mostly in a narrow 150-microns dermal zone beneath chambers containing the phospholipid agonist. Finally, the leukocytic exudate recovered at 3 hours consisted of neutrophils and a small number of eosinophils. Thus the skin window model was useful to further characterize the leukocytic exudate, and it suggested that the potent vasoactive effects of the acetylated alkyl phosphoglyceride were limited by local conditions in tissue so as to produce a highly focused inflammatory response.

Full text

PDF
467

Images in this article

474Figure 5
on p.474

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARTLETT G. R. Phosphorus assay in column chromatography. J Biol Chem. 1959 Mar;234(3):466–468. [PubMed] [Google Scholar]
  2. BLIGH E. G., DYER W. J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959 Aug;37(8):911–917. doi: 10.1139/o59-099. [DOI] [PubMed] [Google Scholar]
  3. Benveniste J., Tencé M., Varenne P., Bidault J., Boullet C., Polonsky J. Semi-synthèse et structure proposée du facteur activant les plaquettes (P.A.F.): PAF-acether, un alkyl ether analogue de la lysophosphatidylcholine. C R Seances Acad Sci D. 1979 Nov 26;289(14):1037–1040. [PubMed] [Google Scholar]
  4. Blank M. L., Lee T., Fitzgerald V., Snyder F. A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid). J Biol Chem. 1981 Jan 10;256(1):175–178. [PubMed] [Google Scholar]
  5. Bussolino F., Breviario F., Aglietta M., Sanavio F., Bosia A., Dejana E. Studies on the mechanism of interleukin 1 stimulation of platelet activating factor synthesis in human endothelial cells in culture. Biochim Biophys Acta. 1987 Jan 19;927(1):43–54. doi: 10.1016/0167-4889(87)90064-4. [DOI] [PubMed] [Google Scholar]
  6. Demopoulos C. A., Pinckard R. N., Hanahan D. J. Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators). J Biol Chem. 1979 Oct 10;254(19):9355–9358. [PubMed] [Google Scholar]
  7. Doebber T. W., Wu M. S., Robbins J. C., Choy B. M., Chang M. N., Shen T. Y. Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone. Biochem Biophys Res Commun. 1985 Mar 29;127(3):799–808. doi: 10.1016/s0006-291x(85)80014-0. [DOI] [PubMed] [Google Scholar]
  8. Handley D. A., Tomesch J. C., Saunders R. N. Inhibition of PAF-induced systemic responses in the rat, guinea pig, dog and primate by the receptor antagonist SRI 63-441. Thromb Haemost. 1986 Aug 20;56(1):40–44. [PubMed] [Google Scholar]
  9. Henocq E., Vargaftig B. B. Accumulation of eosinophils in response to intracutaneous PAF-acether and allergens in man. Lancet. 1986 Jun 14;1(8494):1378–1379. doi: 10.1016/s0140-6736(86)91683-1. [DOI] [PubMed] [Google Scholar]
  10. Humphrey D. M., Cavanaugh C. Microvascular function in skin windows. Am J Pathol. 1987 Mar;126(3):423–431. [PMC free article] [PubMed] [Google Scholar]
  11. Humphrey D. M., Hanahan D. J., Pinckard R. N. Induction of leukocytic infiltrates in rabbit skin by acetyl glyceryl ether phosphorylcholine. Lab Invest. 1982 Sep;47(3):227–234. [PubMed] [Google Scholar]
  12. Humphrey D. M., McManus L. M., Hanahan D. J., Pinckard R. N. Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine. Lab Invest. 1984 Jan;50(1):16–25. [PubMed] [Google Scholar]
  13. Humphrey D. M., McManus L. M., Satouchi K., Hanahan D. J., Pinckard R. N. Vasoactive properties of acetyl glyceryl ether phosphorylcholine and analogues. Lab Invest. 1982 Apr;46(4):422–427. [PubMed] [Google Scholar]
  14. Hwang S. B., Li C. L., Lam M. H., Shen T. Y. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist. Lab Invest. 1985 Jun;52(6):617–630. [PubMed] [Google Scholar]
  15. Issekutz A. C., Szpejda M. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988. Lab Invest. 1986 Mar;54(3):275–281. [PubMed] [Google Scholar]
  16. Kaley G., Hintze T. H., Panzenbeck M., Messina E. J. Role of prostaglandins in microcirculatory function. Adv Prostaglandin Thromboxane Leukot Res. 1985;13:27–35. [PubMed] [Google Scholar]
  17. Lagente V., Fortes Z. B. Role of PAF-acether in the vascular events of inflammation. Prog Biochem Pharmacol. 1988;22:149–155. [PubMed] [Google Scholar]
  18. Prescott S. M., Zimmerman G. A., McIntyre T. M. Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc Natl Acad Sci U S A. 1984 Jun;81(11):3534–3538. doi: 10.1073/pnas.81.11.3534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Stafforini D. M., McIntyre T. M., Carter M. E., Prescott S. M. Human plasma platelet-activating factor acetylhydrolase. Association with lipoprotein particles and role in the degradation of platelet-activating factor. J Biol Chem. 1987 Mar 25;262(9):4215–4222. [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES